药物化学的突破：新靶点与新机制、新药、新希望⁻4。
Breakthroughs in Medicinal Chemistry: New Targets and Mechanisms, New Drugs, New Hopes⁻4.
机构信息
Discipline of Clinical Pharmacology, College of Medicine and Public Health, Flinders University and Flinders Medical Centre, Bedford Park, SA 5042, Australia.
Institut de Chimie des Substances Naturelles, CNRS UPR 2301, Unversité de Paris-Saclay, France.
出版信息
Molecules. 2018 Dec 31;24(1):130. doi: 10.3390/molecules24010130.
Abstract
Breakthroughs in Medicinal Chemistry: New Targets and Mechanisms, New Drugs, New Hopes is a series of Editorials, which is published on a biannual basis by the Editorial Board of the Medicinal Chemistry section of the journal . [...].
摘要
《药物化学的突破：新靶点与新机制、新药、新希望》是由该期刊药物化学分部编辑委员会出版的一系列社论，每两年出版一次。
相似文献
1
Breakthroughs in Medicinal Chemistry: New Targets and Mechanisms, New Drugs, New Hopes⁻4.
Molecules. 2018 Dec 31;24(1):130. doi: 10.3390/molecules24010130.
2
Breakthroughs in Medicinal Chemistry: New Targets and Mechanisms, New Drugs, New Hopes-2.
Molecules. 2017 Dec 28;23(1):65. doi: 10.3390/molecules23010065.
3
Breakthroughs in Medicinal Chemistry: New Targets and Mechanisms, New Drugs, New Hopes-5.
Molecules. 2019 Jun 30;24(13):2415. doi: 10.3390/molecules24132415.
4
Breakthroughs in Medicinal Chemistry: New Targets and Mechanisms, New Drugs, New Hopes-6.
Molecules. 2019 Dec 28;25(1):119. doi: 10.3390/molecules25010119.
5
Breakthroughs in Medicinal Chemistry: New Targets and Mechanisms, New Drugs, New Hopes-7.
Molecules. 2020 Jun 28;25(13):2968. doi: 10.3390/molecules25132968.
6
Breakthroughs in Medicinal Chemistry: New Targets and Mechanisms, New Drugs, New Hopes.
Molecules. 2017 May 5;22(5):743. doi: 10.3390/molecules22050743.
7
Multi-target drug discovery in medicinal chemistry: current status and future perspectives.
Mini Rev Med Chem. 2015;15(8):606-7. doi: 10.2174/1389557515666150219121119.
8
Drug discovery summit: 11(th) Swiss Course on Medicinal Chemistry.
ChemMedChem. 2015 Mar;10(3):575-9. doi: 10.1002/cmdc.201402543. Epub 2015 Jan 14.
9
Editorial: Medicinal chemistry update and discovery strategies on potential therapeutic targets.
Curr Top Med Chem. 2014;14(17):1939. doi: 10.2174/156802661417141020103547.
10
Alpine drug discovery summit: 10th Swiss Course on Medicinal Chemistry.
ChemMedChem. 2012 Dec;7(12):2237-40. doi: 10.1002/cmdc.201200501. Epub 2012 Nov 23.
本文引用的文献
1
Structure-function-guided exploration of the antimicrobial peptide polybia-CP identifies activity determinants and generates synthetic therapeutic candidates.
Commun Biol. 2018 Dec 7;1:221. doi: 10.1038/s42003-018-0224-2. eCollection 2018.
2
Functional Peptide Nanofibers with Unique Tumor Targeting and Enzyme-Induced Local Retention Properties.
Adv Funct Mater. 2018 Oct 31;28(44). doi: 10.1002/adfm.201803969. Epub 2018 Sep 14.
3
Synthesis of new betulinic acid/betulin-derived dimers and hybrids with potent antimalarial and antiviral activities.
Bioorg Med Chem. 2019 Jan 1;27(1):110-115. doi: 10.1016/j.bmc.2018.11.018. Epub 2018 Nov 14.
4
Lung-restricted inhibition of Janus kinase 1 is effective in rodent models of asthma.
Sci Transl Med. 2018 Nov 21;10(468). doi: 10.1126/scitranslmed.aao2151.
5
Targeting CDK9 Reactivates Epigenetically Silenced Genes in Cancer.
Cell. 2018 Nov 15;175(5):1244-1258.e26. doi: 10.1016/j.cell.2018.09.051. Epub 2018 Oct 25.
6
Pharmacological targeting of mitochondria in cancer stem cells: An ancient organelle at the crossroad of novel anti-cancer therapies.
Pharmacol Res. 2019 Jan;139:298-313. doi: 10.1016/j.phrs.2018.11.020. Epub 2018 Nov 16.
7
Sugar-based bactericides targeting phosphatidylethanolamine-enriched membranes.
Nat Commun. 2018 Nov 19;9(1):4857. doi: 10.1038/s41467-018-06488-4.
8
Small-molecule inhibitor of OGG1 suppresses proinflammatory gene expression and inflammation.
Science. 2018 Nov 16;362(6416):834-839. doi: 10.1126/science.aar8048.
9
Target Validation and Identification of Novel Boronate Inhibitors of the Plasmodium falciparum Proteasome.
J Med Chem. 2018 Nov 21;61(22):10053-10066. doi: 10.1021/acs.jmedchem.8b01161. Epub 2018 Nov 7.
10
Doxycycline, an Inhibitor of Mitochondrial Biogenesis, Effectively Reduces Cancer Stem Cells (CSCs) in Early Breast Cancer Patients: A Clinical Pilot Study.
Front Oncol. 2018 Oct 12;8:452. doi: 10.3389/fonc.2018.00452. eCollection 2018.
Zotero 插件